Zacks.com on MSN

All You Need to Know About Maravai LifeSciences (MRVI) Rating Upgrade to Buy

Maravai LifeSciences Holdings, Inc. (MRVI) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings ...
Nasdaq

All You Need to Know About Entera Bio (ENTX) Rating Upgrade to Buy

Entera Bio Ltd. (ENTX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- ...
Hosted on MSN

ENTX rallies as insiders buy company shares — retail hopes for 'exciting days' ahead

・The company said that the purchases were made at prevailing market prices and in compliance with laws governing insider trading. ・According to a filing with the Securities and Exchange Commission, ...
Nasdaq

Entera Bio (ENTX) to Report Q4 Earnings: What's in the Cards?

We expect investors to focus on the updates related to Entera Bio, Ltd. ENTX pipeline candidates when it reports fourth-quarter 2022 results (expected next month). Shares of Entera Bio have declined ...
The Globe and Mail

Entera Bio Reports 2025 Results, Advances Oral Osteoporosis Pipeline

Entera Bio ( (ENTX)) just unveiled an update. Entera Bio reported its full-year 2025 results on March 27, 2026, highlighting progress on EB613, its lead oral anabolic osteoporosis therapy, and ...